Valuation Stratec SE Deutsche Boerse AG
Stocks
SBS
DE000STRA555
Advanced Medical Equipment & Technology
|
Market Closed -
Deutsche Boerse AG
04:00:01 23/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 22.70 EUR | +0.67% |
|
-9.02% | +2.48% |
| 18/08 | Stratec SE : Deutsche Bank is Neutral | ZD |
| 17/08 | Stratec SE : Deutsche Bank reiterates its Neutral rating | ZD |
Company Valuation: Stratec SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,669 | 983.7 | 553.7 | 362.2 | 272.9 | 273.5 | - | - |
| Change | - | -41.06% | -43.71% | -34.58% | -24.66% | 0.22% | - | - |
| Enterprise Value (EV) 1 | 1,705 | 983.7 | 520.2 | 451.5 | 385.4 | 365.7 | 369.7 | 367.7 |
| Change | - | -42.32% | -47.12% | -13.2% | -14.65% | -5.09% | 1.08% | -0.55% |
| P/E | 42x | 33.8x | 42.6x | 22.6x | -1,123x | 20.7x | 15x | 13.2x |
| PBR | 8.12x | - | 2.37x | 1.49x | 1.15x | 1.13x | 1.1x | 1.05x |
| PEG | - | -1.3x | -0.8x | 1x | 11x | -0x | 0.4x | 1x |
| Capitalization / Revenue | 5.81x | 3.58x | 2.11x | 1.41x | 1.09x | 1.04x | 0.97x | 0.92x |
| EV / Revenue | 5.94x | 3.58x | 1.99x | 1.75x | 1.54x | 1.4x | 1.3x | 1.24x |
| EV / EBITDA | 25.6x | 16.8x | 12.5x | 9.17x | 9.48x | 9.1x | 7.7x | 7.08x |
| EV / EBIT | 31.4x | 21.8x | 19.2x | 13.5x | 15.3x | 15.8x | 12.4x | 10.6x |
| EV / FCF | 39.4x | - | 46.9x | 11.6x | -23.1x | 10.8x | 19.9x | 23.1x |
| FCF Yield | 2.54% | - | 2.13% | 8.6% | -4.32% | 9.27% | 5.03% | 4.32% |
| Dividend per Share 2 | 0.952 | - | 0.55 | 0.6 | 0.6 | 0.6364 | 0.7711 | 0.8574 |
| Rate of return | 0.69% | - | 1.21% | 2.01% | 2.67% | 2.83% | 3.43% | 3.81% |
| EPS 2 | 3.28 | 2.4 | 1.07 | 1.32 | -0.02 | 1.084 | 1.505 | 1.705 |
| Distribution rate | 29% | - | 51.4% | 45.5% | -3,000% | 58.7% | 51.2% | 50.3% |
| Net sales 1 | 287.3 | 274.6 | 261.9 | 257.6 | 250.9 | 261.9 | 283.3 | 297 |
| EBITDA 1 | 66.61 | 58.58 | 41.58 | 49.21 | 40.64 | 40.18 | 48 | 51.96 |
| EBIT 1 | 54.27 | 45.05 | 27.07 | 33.46 | 25.17 | 23.2 | 29.81 | 34.78 |
| Net income 1 | 39.96 | 29.22 | 13.07 | 16.02 | -0.242 | 13.21 | 18.23 | 19.99 |
| Net Debt 1 | 36.57 | - | -33.53 | 89.25 | 112.5 | 92.22 | 96.19 | 94.15 |
| Reference price 2 | 137.80 | 81.10 | 45.55 | 29.80 | 22.45 | 22.50 | 22.50 | 22.50 |
| Nbr of stocks (in thousands) | 12,111 | 12,130 | 12,156 | 12,156 | 12,156 | 12,156 | - | - |
| Announcement Date | 30/3/22 | 28/3/23 | 28/3/24 | 19/5/25 | 28/4/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 32.73x | 5.73x | 21.97x | 0.28% | 243B | ||
| 37.29x | 6.68x | 21.19x | 0.64% | 155B | ||
| 43.58x | 11.52x | 25.44x | -.--% | 142B | ||
| 16.99x | 3.47x | 11.28x | -.--% | 65.1B | ||
| 35.08x | 7.03x | 22.25x | -.--% | 51.17B | ||
| 18.43x | 2.25x | 11.4x | 2.74% | 47.67B | ||
| 32.58x | 6.45x | 21.9x | 0.61% | 47.16B | ||
| 74.54x | 7.11x | 21.69x | -.--% | 41.83B | ||
| 50.03x | 8.06x | 28.44x | -.--% | 37.37B | ||
| Average | 37.92x | 6.48x | 20.62x | 0.47% | 92.36B | |
| Weighted average by Cap. | 36.40x | 6.82x | 21.26x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SBS Stock
- SBS Stock
- Valuation Stratec SE
Select your edition
All financial news and data tailored to specific country editions
















